Poehling Capital Management, Inc. Geron Corp Transaction History
Poehling Capital Management, Inc.
- $373 Million
- Q1 2024
A detailed history of Poehling Capital Management, Inc. transactions in Geron Corp stock. As of the latest transaction made, Poehling Capital Management, Inc. holds 75,501 shares of GERN stock, worth $329,184. This represents 0.07% of its overall portfolio holdings.
Number of Shares
75,501
Previous 60,500
24.8%
Holding current value
$329,184
Previous $127,000
96.06%
% of portfolio
0.07%
Previous 0.04%
Shares
12 transactions
Others Institutions Holding GERN
# of Institutions
250Shares Held
374MCall Options Held
1.48MPut Options Held
1.18M-
Black Rock Inc. New York, NY41.4MShares$181 Million0.0% of portfolio
-
State Street Corp Boston, MA31.6MShares$138 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT30.5MShares$133 Million3.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.9MShares$130 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$119 Million12.02% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.65B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...